Scott M. Wasserman
Private Equity Investor bei Frazier Management LLC
Profil
Scott M.
Wasserman is a Venture Partner at Frazier Management LLC since 2023.
Prior to this, he was the Chief Executive Officer at Latigo Biotherapeutics, Inc. from 2019 to 2023 and Vice President & Global Development at Amgen, Inc. from 2015 to 2019.
Wasserman received his undergraduate degree from Haverford College in 1992, his graduate degree from Harvard Medical School in 1997, and his undergraduate degree from Stanford University School of Medicine in 2004.
Aktive Positionen von Scott M. Wasserman
Unternehmen | Position | Beginn |
---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Private Equity Investor | 01.10.2023 |
Ehemalige bekannte Positionen von Scott M. Wasserman
Unternehmen | Position | Ende |
---|---|---|
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Vorstandsvorsitzender | 01.06.2023 |
AMGEN INC. | Private Equity Investor | 01.05.2019 |
Ausbildung von Scott M. Wasserman
Haverford College | Undergraduate Degree |
Harvard Medical School | Graduate Degree |
Stanford University School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Latigo Biotherapeutics, Inc. is a drug discovery company based in Thousand Oak, CA. Latigo Biotherapeutics, Inc. focuses on developing novel, non-opioid therapies for chronic pain. Desmond Padhi has been the CEO of the company since 2024. | Health Technology |